NASDAQ:INMD

InMode (INMD) Stock Price, News & Analysis

InMode logo
$12.42 -0.28 (-2.20%)
Closing price 03:59 PM Eastern
Extended Trading
$12.42 +0.01 (+0.04%)
As of 04:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About InMode Stock (NASDAQ:INMD)

Advanced

Key Stats

Today's Range
$12.40
▼
$12.69
50-Day Range
$12.70
▼
$14.90
52-Week Range
$12.40
▼
$16.67
Volume
706,622 shs
Average Volume
781,162 shs
Market Capitalization
$713.90 million
P/E Ratio
10.26
Dividend Yield
N/A
Price Target
$16.33
Consensus Rating
Hold

Company Overview

InMode Ltd. is an Israel-based medical technology company that develops energy-based systems for minimally invasive aesthetic and medical procedures. Its technologies use radiofrequency energy to support treatments such as body contouring, skin tightening and facial rejuvenation, as well as certain women’s health applications.

The company’s product portfolio includes platforms and handpieces such as BodyTite and FaceTite for body and facial contouring, and Morpheus8 for fractional radiofrequency skin treatments. InMode sells its systems to physicians and other medical professionals, serving customers in the United States and international markets through a combination of direct sales and distribution partners.

Founded in 2008, InMode is headquartered in Yokneam, Israel. The company was co-founded by Moshe Mizrahy, who has served as its chief executive officer, and Dr. Michael Kreindel.

AI Generated. May Contain Errors.

InMode Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
43rd Percentile Overall Score

INMD MarketRank™: 
2.1329772665 of 5 stars

InMode scored higher than 43% of companies evaluated by MarketBeat, and ranked 603rd out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InMode has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 1 sell rating.

  • Upside Potential

    InMode has a consensus price target of $16.33, representing about 30.3% upside from its current price of $12.54.

  • Amount of Analyst Coverage

    InMode has only been the subject of 2 research reports in the past 90 days.

  • Read more about InMode's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InMode is 10.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.39.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InMode is 10.36, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.64.

  • Price to Book Value per Share Ratio

    InMode has a P/B Ratio of 1.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.24% of the float of InMode has been sold short.
  • Short Interest Ratio / Days to Cover

    InMode has a short interest ratio ("days to cover") of 4.79.
  • Change versus previous month

    Short interest in InMode has recently increased by 2.33%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    InMode does not currently pay a dividend.

  • Dividend Growth

    InMode does not have a long track record of dividend growth.

  • News Sentiment

    InMode has a news sentiment score of -0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for InMode this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, InMode insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    6.92% of the stock of InMode is held by insiders.

  • Percentage Held by Institutions

    68.04% of the stock of InMode is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InMode's insider trading history.
Receive INMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InMode and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INMD Stock News Headlines

Head to Head Review: InMode (INMD) versus The Competition
Canaccord Genuity Keeps Their Hold Rating on InMode (INMD)
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
InMode Reports Third-Quarter 2026 Revenue of $92.1 Million
InMode (NASDAQ:INMD) Stock Price Target Lowered at Robert W. Baird
Inmode Q3 Income Declines
See More Headlines

INMD Stock Analysis - Frequently Asked Questions

InMode's stock was trading at $14.69 on January 1st, 2026. Since then, INMD stock has decreased by 14.7% and is now trading at $12.5350.

InMode Ltd. (NASDAQ:INMD) announced its quarterly earnings data on Wednesday, November, 11th. The healthcare company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.05. InMode's revenue for the quarter was down 1.1% on a year-over-year basis.

Shares of InMode split on Thursday, September 30th 2021.The 2-1 split was announced on Friday, September 17th 2021. The newly minted shares were payable to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

InMode subsidiaries include these companies: Guangzhou InMode Medical Technology Ltd., InMode Asia Limited., InMode India Private Limited, InMode Japan KK, InMode M.D. Ltd., Invasix Corp., Invasix Iberia S.L., Invasix Inc., and Invasix UK Ltd..

InMode (INMD) raised $75 million in an IPO on Thursday, August 8th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

Top institutional shareholders of InMode include State Street Corp (1.25%), Lind Value II ApS (0.75%), Alberta Investment Management Corp (0.34%) and CWA Asset Management Group LLC (0.30%).

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InMode investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), PayPal (PYPL), Tesla (TSLA), CrowdStrike (CRWD), Block (XYZ) and Salesforce (CRM).

Company Calendar

Last Earnings
11/11/2026
Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:INMD
CIK
1742692
Fax
N/A
Employees
660
Year Founded
2008

Price Target and Rating

High Price Target
$19.00
Low Price Target
$15.00
Potential Upside/Downside
+31.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.21
Trailing P/E Ratio
10.26
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$93.83 million
Net Margins
19.94%
Pretax Margin
23.43%
Return on Equity
11.55%
Return on Assets
10.18%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.58
Quick Ratio
7.28

Sales & Book Value

Annual Sales
$370.49 million
Price / Sales
1.93
Cash Flow
$1.44 per share
Price / Cash Flow
8.63
Book Value
$11.33 per share
Price / Book
1.10

Miscellaneous

Outstanding Shares
57,480,000
Free Float
53,503,000
Market Cap
$713.90 million
Optionable
Optionable
Beta
1.98

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NASDAQ:INMD) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners